Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000473909 | SCV000250347 | benign | not provided | 2019-05-22 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000196068 | SCV000297013 | benign | not specified | 2015-10-20 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000196068 | SCV000331587 | benign | not specified | 2016-09-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001084884 | SCV000556049 | likely benign | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000196068 | SCV000594796 | likely benign | not specified | 2016-03-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004020363 | SCV000738383 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-01-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Human Genetics, |
RCV000680536 | SCV000807945 | likely benign | Connective tissue disorder | 2018-06-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000473909 | SCV001150527 | uncertain significance | not provided | 2016-05-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000196068 | SCV001475120 | benign | not specified | 2020-08-27 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000473909 | SCV002048947 | benign | not provided | 2022-06-30 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000196068 | SCV004039151 | likely benign | not specified | 2023-08-14 | criteria provided, single submitter | clinical testing | Variant summary: FLNA c.5251C>T (p.Pro1751Ser) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00074 in 166980 control chromosomes, predominantly at a frequency of 0.001 within the Non-Finnish European subpopulation in the gnomAD database, including 1 homozygotes and 24 hemizygotes. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 3200 fold of the estimated maximal expected allele frequency for a pathogenic variant in FLNA causing Periventricular Nodular Heterotopia phenotype (3.1e-07), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. To our knowledge, no occurrence of c.5251C>T in individuals affected with Periventricular Nodular Heterotopia and no experimental evidence demonstrating its impact on protein function have been reported. Ten submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified as benign/likely benign (n=9) and VUS (n=1). Based on the evidence outlined above, the variant was classified as likely benign. |
Diagnostic Laboratory, |
RCV000473909 | SCV001744767 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000473909 | SCV001798685 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000473909 | SCV001927416 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000473909 | SCV001968943 | likely benign | not provided | no assertion criteria provided | clinical testing |